This leads to constructing a mechanism-based mathematical model that allows capturing the interaction of different phosphorylated forms of PAGE4 with AP-1 and its downstream target, the androgen receptor, a key therapeutic target in PCa (49). Here, FOS is linked to posterior cortical atrophy.